Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19

被引：0
|
作者：
Lv, Xiu-He [1 ,2 ]
Yang, Jin-Lin [1 ,2 ]
Deng, Kai [1 ,2 ,3 ,4 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Sichuan Univ Oxford Univ Huaxi Gastrointestinal C, Dept Gastroenterol & Hepatol, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, COVID 19 Med Team Hubei, Chengdu, Sichuan, Peoples R China
[4] Wuhan Univ, Renmin Hosp, East Branch, COVID 19 Med Team Hubei,West China Hosp, Wuhan, Hubei, Peoples R China
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷 / 05期
关键词：
LOPINAVIR/RITONAVIR;
D O I：
10.14309/ajg.0000000000001043
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1099 / 1099
页数：1
相关论文
共 50 条
  • [1] A Trial of Lopinavir-Ritonavir in Covid-19
    Carmona-Bayonas, Alberto
    Jimenez-Fonseca, Paula
    Castanon, Eduardo
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21):
  • [2] Lopinavir-ritonavir in severe COVID-19
    Stower, Hannah
    NATURE MEDICINE, 2020, 26 (04) : 465 - 465
  • [3] A Trial of Lopinavir-Ritonavir in Covid-19 Reply
    Cao, Bin
    Zhang, Dingyu
    Wang, Chen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21):
  • [4] BET 1: LOPINAVIR-RITONAVIR AND COVID-19
    Dolan, Daniel
    Ingham, Jack
    Baombe, Janos
    EMERGENCY MEDICINE JOURNAL, 2020, 37 (07) : 450 - +
  • [5] No Benefit for Lopinavir-Ritonavir in Severe COVID-19
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20): : 1999 - 1999
  • [6] A severe COVID-19 despite ongoing treatment with Lopinavir-Ritonavir
    Joumaa, H.
    Regard, L.
    Carlier, N.
    Chassagnon, G.
    Alabadan, E.
    Canoui, E.
    L'honneur, A.
    Rozenberg, F.
    Burgel, P. -R.
    Roche, N.
    RESPIRATORY MEDICINE AND RESEARCH, 2020, 78
  • [7] A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
    Cao, B.
    Wang, Y.
    Wen, D.
    Liu, W.
    Wang, Jingli
    Fan, G.
    Ruan, L.
    Song, B.
    Cai, Y.
    Wei, M.
    Li, X.
    Xia, J.
    Chen, N.
    Xiang, J.
    Yu, T.
    Bai, T.
    Xie, X.
    Zhang, L.
    Li, C.
    Yuan, Y.
    Chen, H.
    Li, Huadong
    Huang, H.
    Tu, S.
    Gong, F.
    Liu, Y.
    Wei, Y.
    Dong, C.
    Zhou, F.
    Gu, X.
    Xu, J.
    Liu, Z.
    Zhang, Y.
    Li, Hui
    Shang, L.
    Wang, K.
    Li, K.
    Zhou, X.
    Dong, X.
    Qu, Z.
    Lu, S.
    Hu, X.
    Ruan, S.
    Luo, S.
    Wu, J.
    Peng, L.
    Cheng, F.
    Pan, L.
    Zou, J.
    Jia, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19): : 1787 - 1799
  • [8] Lopinavir-ritonavir versus darunavir-norvir for hospitalized COVID-19 patients
    Paroczai, Dora
    Bikov, Andras
    Blidaru, Andreea
    Bobu, Emanuel
    Cerbu, Bianca
    Marincu, Iosif
    Mihaicuta, Stefan
    Frent, Stefan
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [9] Assessing the Clinical Improvement in Patients with COVID-19 using Lopinavir-Ritonavir: A Systematic Review
    Magadmi, Rania M.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (44A) : 448 - 459
  • [10] Crushing lopinavir-ritonavir tablets may decrease the efficacy of therapy in COVID-19 patients
    Eljaaly, Khalid
    Al-Tawfiq, Jaffar A.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 38
12345